Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown.
about
Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical ImplicationsImbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.Upregulation of OLR1 and IL17A genes and their association with blood glucose and lipid levels in femoropopliteal artery diseaseMechanisms that regulate macrophage burden in atherosclerosis.The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patientsEthanolic extract of propolis inhibits atherosclerosis in ApoE-knockout mice.Where Does Inflammation Fit?Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders.IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?The Th17/Treg imbalance in patients with cardiogenic shock.Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets.Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine.The Relationship between Tuberculosis and Lung Cancer.Potential Immunological Links Between Psoriasis and Cardiovascular Disease.Gene expression pattern of TCR repertoire and alteration expression of IL-17A gene of γδ T cells in patients with acute myocardial infarction.
P2860
Q30241848-0842239A-B925-417D-815E-FFD1C789D901Q31133324-A391136A-431A-41B7-B10C-C2507300EB48Q33598191-630A7C83-892F-4469-877A-C8ECACA2916AQ33761114-B35158AF-AEF8-4237-897B-97BB68397B8EQ34309016-D9430FB3-456E-4CB9-9005-3CAA29C0958FQ37115200-DC1A1BF6-6D8B-40F9-9E64-7BA32829129DQ38639570-9FDB922F-6064-41A3-91C7-5CD281AF9AE9Q38970666-3CA3327A-1180-458A-9D49-15A20838FF25Q41104626-6BAECE7C-585D-494E-9B90-2587366BC2E5Q44663401-186B4F12-0AE5-4741-8A83-64F2FABD5EFFQ47756011-1AFC2C54-ED75-424B-A68F-3256C5916DA4Q54488428-AD1C024B-BB82-45A1-84F1-FFB0EB7C77BFQ55007740-67D9B15B-96A8-4B1A-A723-6AB96CE6B21AQ55270893-D14C6B9A-3B21-44C6-92C8-C0CC3AFD8799Q55613890-6C65B564-AF5C-4E6C-A50E-63E12EC51D71
P2860
Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Interleukin-17 in atherosclero ...... ood, the bad, and the unknown.
@en
Interleukin-17 in atherosclero ...... ood, the bad, and the unknown.
@nl
type
label
Interleukin-17 in atherosclero ...... ood, the bad, and the unknown.
@en
Interleukin-17 in atherosclero ...... ood, the bad, and the unknown.
@nl
prefLabel
Interleukin-17 in atherosclero ...... ood, the bad, and the unknown.
@en
Interleukin-17 in atherosclero ...... ood, the bad, and the unknown.
@nl
P2860
P356
P1476
Interleukin-17 in atherosclero ...... good, the bad, and the unknown
@en
P2093
Daniela Pedicino
Francesco Trotta
P2860
P304
P356
10.1093/EURHEARTJ/EHS399
P577
2012-11-23T00:00:00Z